Photonz - producing high purity EPA from algal fermentation
Photonz Corporation is a biotechnology company producing the omega-3 fatty acid eicosapentaenoic acid (EPA) from its primary source, marine microalgae. EPA is a critical ingredient in regulated pharmaceutical products and medicinal foods addressing cardiovascular disease.
Globally there is significant demand for pharmaceuticals using EPA as an active ingredient and this demand is increasing rapidly. Currently, the majority of EPA is extracted from wild fish oil - a limited and variable secondary source at risk of collapse. Photonz bypasses fish oil and any associated contaminants and pollutants and produces EPA directly from a microalgal source through a unique fermentation process, which confers a number of advantages.
Photonz fermentation product PNZ0901, is produced using Photonz' proprietary algal fermentation technology which overcomes a number of obstacles previously encountered in continuous fermentation of microalgae.
The Company owns or controls seven patent families covering fermentation and purification of microalgal EPA.